Avita Medical secures 10-year BARDA agreement worth $25.5M

Avita Medical (RCEL) announced it has entered into a 10-year agreement with the Biomedical Advanced Research and Development Authority, or BARDA, part of the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services. The agreement, awarded under Project BioShield and valued at up to $25.5M, is intended to strengthen national preparedness for burn mass casualty incidents. Under the agreement, Avita Medical will: maintain an inventory of Recell products available for immediate deployment upon notice from BARDA and support surge procurement of additional product, ensuring scalable emergency response capacity and rovide logistics, quality assurance, and deployment readiness to meet BARDA’s mission for preparedness.